Pharma News India
The drug firm gets USFDA nod for the Rizatriptan Benzoate Tablets used in the treatment of migraine.
Hyderabad, January 1, 2013: Aurobindo Pharma has received the final approval from US Food and Drug Administration (USFDA) to manufacture and market Rizatriptan Benzoate Tablets used in the treatment of migraine.
The Indian pharma firm has bagged two patents from Eurasia and One from Canada
Hyderabad, December 31, 2012: Suven Life Sciences has secured three product patents, two from Eurasia and one from Canada. It is worth noting here that the granted claims of the patents include the class of selective 5-HT compounds discovered by the Hyderabad-based company and were being developed as ther...
The approval from USFDA allows the Indian pharma company to manufacture and market Nafcillin injections.
Hyderabad, December 27, 2012: Aurobindo Pharma Ltd has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Nafcillin injections. It is worth noting here that Nafcillin for injection is a sterile semisynthetic penicillin (SSP) indi...
The agreement between the two firms aims at developing molecules to treat chronic inflammatory conditions.
New Delhi, December 24, 2012: Glenmark Pharmaceuticals has signed an agreement with the US-based Forest Laboratories Inc to develop molecules to treat chronic inflammatory conditions. As per the agreement, Glenmark will receive up to Rs 50 crore (US$ 9 million) from the US-b...
The approval is a green signal for the pharma company to market the product in the US.
New Delhi, December 19, 2012: Natco Pharma has received the approval from the US regulator, Food and Drug Administration (FDA) to market the anti-ulcer drug, Lansoprazole delayed release capsules in the US market.